Generic Name: Empagliflozin
Brand Name: Jardiance
Manufacturer: Boehringer Ingelheim (Canada) Ltd.
Therapeutic Area: Diabetes mellitus, type 2
Indications: Diabetes mellitus (Type 2)
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: October 15, 2015
Recommendation Type: List with clinical criteria and/or conditions